Tumor Specificity Services
-
Manufactured by Creative Biogenebased in USA
cells. Through the combination of the tumor-specific cell lysis and immune stimulation, OVs act their antitumor activities in situ. OVs encompass a broad diversity of DNA and RNA viruses, typically fall into 2 classes: 1) viruses that are naturally cancer-selective such as reovirus, 2) viruses that are genetically-manipulated including measles ...
-
Manufactured by ITM Isotope Technologies Munich SEbased in GERMANY
and binds to the tumor specific receptor according to a lock and key ...
-
based in USA
platform developed and optimized to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific microenvironment in only 4 days using PDX-O (patient-derived xenograft organoids) collected with matched, autologous TIL ...
-
Manufactured by Targazyme, Inc.based in USA
TILs are part of the body’s natural response to cancer:The cells of the immune system perform immunosurveillance while circulating throughout the bodyAs part of the normal immune response, TIL migrate to the tumor site through recognition of chemokines produced by the tumor. TIL recognize tumors through ...
-
Manufactured by Immatics N.V.based in GERMANY
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
-
based in CANADA
Gene fusions are the result of other genomic events, such as translocation, interstitial deletion, or chromosomal inversion. Gene fusions are known to be driver mutations in many different tumors and more recently, have emerged as therapeutic targets. While relatively rare, for example ALK rearrangements have been reported as occurring in only ...
-
based in USA
Empowering better decisions through unique, cell-based tissue analysis. Flagship’s pathologist-driven image analysis generates unique cellular data profiles that allow for flexible yet robust quantitative solutions. With one of the largest tissue image analysis operations in the world, we provide contextual biomarker data services powered by proprietary image analysis technology. Our ...
-
based in UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
-
based in CANADA
mutations, and mutations with prognostic and diagnostic implications for care. Find It helps oncologists to tailor treatments based on the genomic mutations in their patients’ tumors for more personalized cancer ...
-
based in CANADA
alternative or complement to tissue assays. Plasma assays also provide the added potential for economical and minimally invasive serial sampling. Follow It is an amplicon-based focused liquid biopsy panel that analyzes cell-free circulating tumor DNA (ctDNA) in plasma isolated from peripheral blood. The assay is designed to detect SNVs and CNVs ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you